Monographie - Bupivacaine hydrochloride

Última actualización :
28/04/2024

Bupivacaine hydrochloride

Factores que influyen sobre la estabilidad

Estructura química

Nombre comercial

Los nombres comerciales son orientativos y los excipientes de la formulación pueden ser distintos dependiendo del país y del laboratorio fabricante.

Bicain	Finlandia
Bucain	Alemania, Austria
Bucaine	Arabia Saudita
Bupi Alleman	Alemania
Bupinest	Colombia, Ecuador
Bupirop	Ecuador
Bupisen	Italia
Bupivacain	Alemania
Bupivacaina	Chile, España
Bupivacaine	Australia, Gran Bretaña, Irlanda, Marruecos, Túnez
Bupivan	Alemania, Chile
Buvacaina	México
Buvasin	Turquía
Carbostesin	Alemania, Austria
Dolanaest	Alemania, Austria
Duracaine	Argentina
Inibsacain	España
Marcain	Australia, Dinamarca, Egipto, Malasia, Nueva Zelanda
Marcaine	Bélgica
Sensorcaine	Canadá
Sinebupiv	Ecuador

Bibliografía : Bupivacaine hydrochloride

	Tipo	Publicación
60	Periódico	Tu YH, Stiles ML, Allen LV Jr. Stability of fentanyl citrate and bupivacaine hydrochloride in portable pump reservoirs. Am J Hosp Pharm 1990 ; 47: 2037-2040.
217	Periódico	Allen LV, Stiles ML, Wang DP, Tu YH. Stability of bupivacaine hydrochloride, epinephrine hydrochloride, and fentanyl citrate in portable infusion-pump reservoirs. Am J Hosp Pharm 1993 ; 50: 714-715.
220	Periódico	Johnson CE, Christen C, Perez MM, Ma M. Compatibility of bupivacaine hydrochloride and morphine sulfate. Am J Health-Syst Pharm 1997 ; 54: 61-64.
221	Periódico	Neels JT. Compatibility of bupivacaine hydrochloride with hydromorphone hydrochloride or morphine sulfate. Am J Hosp Pharm 1992 ; 49: 2149.
293	Periódico	Jones JW, Davis AT. Stability of bupivacaine hydrochloride in polypropylene syringes. Am J Hosp Pharm 1993 ; 50: 2364-2365.
306	Periódico	Christen C, Johnson CE, Walters JR. Stability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministration. Am J Health-Syst Pharm 1996 ; 53: 170-173.
346	Periódico	Wulf H, Gleim M, Mignat C. The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes. J Pain Symptom Manage 1994 ; 9: 308-311.
507	Periódico	Dawson PJ, Bjorksten AR, Duncan IP, Barnes RK, Beemer GH. Stability of fentanyl, bupivacaine and adrenaline solutions for extradural infusion. Br J Anaesth 1992 ; 68: 414-417.
510	Periódico	Roos PJ, Glerum JH, Schroeders MJH. Effect of glucose 5% solution and bupivacaine hydrochloride on absorption of sufentanil citrate in a portable pump reservoir during storage and simulated infusion by an epidural catheter. Pharm World Sci 1993 ; 15: 269-275.
512	Periódico	Barnes AR, Nash S. Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion. Pharm World Sci 1995 ; 17: 87-92.
529	Periódico	Van Asten P, Glerum JH, Spaanderman ER, Van Niekerk J, Van Dijk A. Compatibility of bupivacaine and iohexol in two mixtures for paediatric regional anaesthesia. Pharm Weekbl [Sci] 1991 ; 13: 254-256.
1276	Periódico	Shiffman E, Walker SE, Yoon T, Yeung M. Stability and compatibility of morphine with bupivacaine. Can J Hosp Pharm 1998 ; 51: 110-116.
1292	Periódico	Grassby PF, Roberts DE. Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags. Int J Pharm Pract 1995 ; 3: 174-177.
1491	Periódico	Brouwers JRBJ, van Doorne H, Meevis RF, Boersma FP. Stability of sufentanil citrate and sufentanil citrate/bupivacaine mixture in portable infusion pump reservoirs. Eur Hosp Pharm 1995 ; 1: 12-14.
1707	Periódico	Trissel LA, Xu QA, Pham L. Physical and chemical stability of low and high concentrations of morphine sulfate with bupivacaine hydrochloride packaged in plastic syringes. Int J Pharm Compound 2002 ; 6: 70-73.
1723	Periódico	Sattler A, Jage J, Krämer I. Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine. Pharmazie 1998 ; 53: 386-391.
1875	Periódico	Kjonniksen I, Brustugun J, Breivik H, Anderssen E, Klem W. Stability of an epidural analgesic solution containing adrenaline, bupivacaine and fentanyl. Acta Anaesthesiol Scand 2000 ; 44: 864-867.
1879	Periódico	Hildebrand KR, Elsberry DE, Deer TR. Stability, compatibility, and safety of intrathecal bupivacaine administered via an implantable delivery system. Clin J Pain 2001 : 17: 239-244.
1885	Periódico	Essink-Tjebbes CM, Burger DM, Beelen, Wuis EW, Heckster YA. Long-term stability of morphine and bupivacaine mixture for spinal use. Pharm World Sci 1999 ; 21: 144-146.
1909	Periódico	Farhang-Asnefi S, Barre J, Callaert S, Boutros A, Causse R, Thebault A. Compatibilité et stabilité du mélange bupivacaïne-sufentanil en poche. J Pharm Clin 2000 ; 19: 248-251.
1931	Periódico	Donnely RF. Physical compatibility and chemical stability of bupivacaine and hydromorphone in polypropylene syringes. Can J Hosp Pharm 2004 ; 4: 230-235.
1948	Periódico	Classen AM, Wimbish GH, Kupiec TC. Stability of admixtures containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system. J Pain Symptom Manage 2004 ; 28, 6: 603-611.
2083	Periódico	La Forgia SP, Sharley NA, Burgess NG, Doecke CJ. Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion. J Pharm Pract and Res 2002 ; 32: 65-68.
2252	Periódico	Shields D, Montenegro R, Aclan J. Chemical stability of admixture combining ziconotide and bupivacaine during simulated intrathecal administration. Neuromodulation 2007 ; 10, 1: 1-5.
2305	Periódico	Bianchi F, Ginggen A, Tardy Y. Stability and compatibility of drug mixtures in an implantable infusion system. Anaesthesia 2008 63, 9: 972-978.
2306	Periódico	Priston M.J, Hughes J.M, Santillo M, Christie I.W. Stability of an epidural analgesic admixture containing epinephrine, fentanyl and bupivacaine. Anaesthesia 2004 ; 59, 10: 979-983.
2307	Periódico	Kreeger L, Cowin P, Noble-Gresty J, Naysmith A. Epidural diamorphine and bupivacaine stability study. Palliative Med 1995 ; 9, 4: 315-318.
2308	Periódico	Hudson S.J, Jones M.F, Nolan S, Ellis H, Duncombe R, Alexander-Williams J.M. Stability of premixed syringes of diamorphine and hyperbaric bupivacaine. Int J Obstet Anesth 2005 ; 14, 4: 284-287.
2319	Periódico	Janssen K, Wisselo R, Geerlings C, Schouten J.P. Chemical stability of a solution of bupivacaine hydrochloride 0.125% and sufentanil citrate 0.5 µg/ml for filling syringes using a repeater pump. EJHP Science 2009 ; 15, 1: 11-14.
3131	Periódico	Donnely RF, Wong K, Spencer J. Physical compatibility of high-concentration bupivacaine with hydromorphone, morphine and fentanyl. Can J Hosp Pharm 2010 ; 63, 2: 154-155.
3184	Laboratorio	Hyaluronidase (Hyalase®) - Summary of Product characteristics. CP Pharmaceuticals 2005
3296	Periódico	Salmeron-Garcia A, Navas N, Martin A, Roman E, Cabeza J, Capitan-Vallvey L.F Determination of Tramadol, Metamizole, Ropivacaine, and Bupivacaine in Analgesic Mixture Samples by HPLC with DAD Detection. J Chromatographic Sci 2009 ; 47: 1-7.
3372	Periódico	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3964	Periódico	Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 2017 ; 50,1 : 27-33.
4200	Periódico	Macorigh C, Guibbert V, Casanova M, Haenni C. Stability study of hydromorphone and bupivacaine mixture by HPLC-UV. EJHP 2018
4319	Periódico	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4603	Periódico	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.
4746	Póster	Shead K, Derrick H, Lyons D, Law S, Ma N.H. Stability and Compatibility of Bupivacaine and Hydromorphone in PVC and non-DEHP bags for 30 days at 4°C and 25°C. 2023

Mentions Légales